Purchase Order 75N90023P00785
Award Date
9/14/23
Potential Completion Date
9/30/23
Potential Value
$25K
Federal Agency
NIH Clinical Center
Awardee
Biomerieux Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Biomerieux Inc. was awarded a $1,333,004 firm fixed price definitive contract by the Department of Health and Human Services National Institutes of Health Clinical Center to deliver a 3P Enterprise Instrument with 3P Connect software. The contract has no set-aside designation and work is to be completed by March 30, 2024 at the stated place of performance in Emigration Canyon, Utah. Biomerieux Inc. will provide their proprietary microbiology analyzer and associated reagents, test kits, controls,...
This is a $75,025.40 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics and laboratory testing solutions. The contract is for the supply of reagents and supplies required for molecular patient care testing, with a period of performance ending on February 8, 2022. The contract does not have a set-aside designation. Biomerieux Inc. is the prime contractor, and there is no information...
This firm-fixed-price purchase order was awarded to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of its specialized clinical diagnostic equipment, reagents, and supplies. The $24,263.76 award is in support of the NIH Clinical Center and does not have a set-aside designation. Biomerieux Inc. holds several significant federal contract Indefinite Delivery Vehicles, including a $194 million Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test...
This federal contract award is to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. Division. The contract, valued at $281,521.87, is a firm-fixed-price purchase order from the National Institutes of Health (NIH) Clinical Center. The award, which does not have a set-aside designation, is for the provision of Biomerieux's specialized diagnostic platforms, consumables, and related services to support infectious disease testing and pathogen detection across...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health Clinical Center to Biomerieux Inc., a foreign-owned for-profit manufacturer of goods. The contract is for the provision of scientific reagents and supplies, with a potential value of $200,184.68 and a completion date of September 30, 2024. The contract does not have a set-aside designation. Biomerieux Inc. is a leader in in vitro diagnostics, providing microbiological...
This is a $24,995.61 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics. The contract is not set aside and involves the provision of Biomerieux's specialized diagnostic technologies, including its VITEK, BioFire, and VIDAS systems, along with associated reagents, test kits, and maintenance services. Biomerieux Inc. has extensive experience in providing diagnostic solutions to...
This $15,970.24 firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc. for BioFire Mycoplasma test kits. The contract has an ultimate completion date of September 30, 2024 and does not have a set-aside designation. Biomerieux Inc., a global in vitro diagnostics leader, provides a range of clinical diagnostic equipment, reagents, and supplies to federal agencies through various Indefinite Delivery Vehicles (IDVs), including...
This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics, through its Biomerieux, Inc. division. The $9,166.20 firm-fixed-price purchase order is for the delivery of Biomerieux's specialized medical diagnostic equipment, reagents, and supplies. The contract does not involve any set-aside designations. Biomerieux Inc. is a experienced federal contractor, holding multiple Indefinite Delivery...
This federal contract award to Biomerieux Inc. was issued by the National Institutes of Health (NIH) Clinical Center for the purchase of diagnostic products and services. The contract has a ceiling value of $88,269.26 and a firm fixed-price pricing type. The contract does not include a set-aside designation. Biomerieux Inc., a global leader in in vitro diagnostics, is providing its proprietary microbial identification and antibiotic susceptibility testing platforms, such as the VITEK and BioFire...
This federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, is for the delivery of the company's proprietary clinical diagnostic equipment, reagents, and supplies to support infectious disease testing and pathogen detection across various government agencies. The $11,064 firm-fixed-price purchase order, awarded by the National Institutes of Health (NIH) Clinical Center, has an ultimate completion date of August 8, 2025. Biomerieux Inc. is the prime contractor and...